Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Novavax, Inc. Could Be a Gold Mine for Growth Investors


Why Novavax, Inc. Could Be a Gold Mine for Growth Investors

If you had the misfortune to buy Novavax (NASDAQ: NVAX) stock in July 2015 and held on, around 90% of your investment would have been wiped out. Ouch. Even if you had bought the biotech stock at the beginning of 2017, you would be losing money.

With that context, the following statement might seem crazy: Novavax could be a gold mine for growth investors. But sometimes it's the craziest ideas that prove to be the most successful. Here's why the growth prospects for Novavax just might be much greater than many think. 

Image source: Getty Images.

Continue reading


Source: Fool.com

Sanofi S.A. ADR Aktie

44,80 €
-0,88 %
Heute muss Sanofi S.A. ADR einen kleinen Kursrückgang von -0,88 % hinnehmen.

Like: 0
SNY
Teilen

Kommentare